Coivas review

Coivas for moms: our verdict

Coivas prints both prices on the same page, which is not common. The cards say semaglutide from $119 and tirzepatide from $199; further down, the comparison table says $149 and $229, marked "after intro period". That second pair is what you pay from month two, and it is the one to budget with. The price is flat at every dose, so moving up a dose does not raise the bill, and it covers all 50 states with the consultation, medication and shipping included. There is no brand-name Wegovy or Zepbound, no tablet, and no mention of blood work anywhere. The advertised starting price is $119, but the regular rate settles nearer $149/mo — so read the headline as an intro offer, not as the monthly cost.

We looked at Coivas the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Coivas actually costs

• Compounded semaglutide — All doses (flat): $119 to start, then $149/mo
• Compounded tirzepatide — All doses (flat): $199 to start, then $229/mo

That lands below the median ongoing price of about $179 across the providers we track for moms — a real cost advantage.

Coivas prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult and the medication.

The medications Coivas prescribes

Coivas lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

Where it operates. Coivas lists its coverage as: All 50 states.

Where Coivas fits — and where it doesn't — for moms

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
• broad access matters to you; confirm treatment eligibility in your current state and any new state before moving.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Coivas, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Coivas is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.